Provided is an application of clostridium ghonii MW-DCG-HNCv-18 in the preparation of medicines for treating non-small-cell lung carcinoma. Also provided is a medicine that is used for treating non-small-cell lung carcinoma and uses clostridium ghonii MW-DCG-HNCv-18 and docetaxel as active ingredients.
申请公布号
WO2016095503(A1)
申请公布日期
2016.06.23
申请号
WO2015CN83573
申请日期
2015.07.08
申请人
SHANDONG CHUANGXIN PHARMACEUTICAL RESEARCH & DEVELOPMENT CO., LTD
